GQG:ASXGQG Partners, Inc. Shs Chess Depository Interests Repr 1 Sh Analysis
Data as of 2026-06-03 - not real-time
A$1.40
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
GQG Partners is trading at AU$1.395, well below its 20‑day, 50‑day and 200‑day moving averages of 1.54, 1.63 and 1.67 respectively, signalling a bearish technical backdrop. The RSI of 25.5 indicates oversold conditions, while a bearish MACD histogram reinforces short‑term downside pressure. Despite the price weakness, the stock boasts a PE of 6.34 versus an industry average of 16.6, a dividend yield of 14.98% and a payout ratio under 80%, suggesting the dividend remains sustainable given robust operating cash flow and a free cash flow conversion of roughly 62%. The DCF model places fair value at AU$1.91, implying a potential upside of about 36%, and the Fear & Greed Index’s “Extreme Greed” reading reflects market appetite for high‑yield assets.
The fundamentals are solid: revenue grew 2% year‑over‑year, margins are exceptionally high (gross 82%, operating 78%, profit 57%), and the balance sheet is strong with cash exceeding debt. Low beta (~0.18) and a 30‑day volatility of 31% point to modest market correlation but elevated price swings. With a max drawdown near 42% historically, downside risk exists, yet the combination of deep valuation discount, attractive dividend and low market sensitivity makes GQG a compelling buy for income‑focused investors who can tolerate short‑term volatility.
The fundamentals are solid: revenue grew 2% year‑over‑year, margins are exceptionally high (gross 82%, operating 78%, profit 57%), and the balance sheet is strong with cash exceeding debt. Low beta (~0.18) and a 30‑day volatility of 31% point to modest market correlation but elevated price swings. With a max drawdown near 42% historically, downside risk exists, yet the combination of deep valuation discount, attractive dividend and low market sensitivity makes GQG a compelling buy for income‑focused investors who can tolerate short‑term volatility.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Oversold RSI suggests possible short‑term bounce
- Price below all major moving averages indicates bearish trend
- High dividend yield provides income cushion
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued relative to DCF fair value and peers
- Sustainable dividend with strong cash flow generation
- Low beta reduces market‑wide exposure
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Consistently high profit margins and cash conversion
- Attractive yield in a low‑interest‑rate environment
- Limited regulatory and geographic headwinds
Key Metrics & Analysis
Financial Health
Revenue Growth2.00%
Profit Margin57.32%
P/E Ratio6.3
ROE107.64%
ROA81.28%
Debt/Equity6.04
P/B Ratio6.6
Op. Cash FlowA$483.1M
Free Cash FlowA$388.3M
Industry P/E16.6
Technical Analysis
TrendBearish
RSI25.6
SupportA$1.39
ResistanceA$1.71
MA 20A$1.54
MA 50A$1.63
MA 200A$1.67
MACDBearish
VolumeStable
Fear & Greed Index92.82
Valuation
Fair ValueA$1.91
Target PriceA$1.90
Upside/Downside35.97%
GradeUndervalued
TypeValue
Dividend Yield14.98%
Risk Assessment
Beta0.18
Volatility31.02%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.